Universe Pharmaceuticals (UPC) Receivables - Net (2020 - 2025)
Universe Pharmaceuticals' Receivables - Net history spans 6 years, with the latest figure at $6.6 million for Q3 2025.
- For Q3 2025, Receivables - Net fell 99.95% year-over-year to $6.6 million; the TTM value through Sep 2025 reached $6.6 million, down 99.95%, while the annual FY2025 figure was $6.6 million, 48.44% down from the prior year.
- Receivables - Net for Q3 2025 was $6.6 million at Universe Pharmaceuticals, down from $13.0 billion in the prior quarter.
- Across five years, Receivables - Net topped out at $13.0 billion in Q3 2024 and bottomed at $6.6 million in Q3 2025.
- The 5-year median for Receivables - Net is $15.2 million (2022), against an average of $2.6 billion.
- The largest annual shift saw Receivables - Net skyrocketed 118293.21% in 2024 before it crashed 99.95% in 2025.
- A 5-year view of Receivables - Net shows it stood at $16.0 million in 2021, then dropped by 5.22% to $15.2 million in 2022, then dropped by 27.46% to $11.0 million in 2023, then surged by 118293.21% to $13.0 billion in 2024, then plummeted by 99.95% to $6.6 million in 2025.
- Per Business Quant, the three most recent readings for UPC's Receivables - Net are $6.6 million (Q3 2025), $13.0 billion (Q3 2024), and $11.0 million (Q3 2023).